These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 2896784

  • 1. Stereoselectivity of kappa-opiate receptor ligands in inhibiting the binding of [3H][3-MeHis2]thyrotrophin releasing hormone to brain membranes.
    Bhargava HN, Das S, Gulati A.
    J Pharm Pharmacol; 1988 Jan; 40(1):70-2. PubMed ID: 2896784
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of [3H][3-MeHis2]thyrotropin releasing hormone recognition sites in the rat brain by tifluadom, a kappa opiate receptor agonist.
    Das S, Bhargava HN.
    Neuropharmacology; 1987 Aug; 26(8):1141-6. PubMed ID: 2889163
    [Abstract] [Full Text] [Related]

  • 3. Differential effects of two kappa-opiate agonists, U-50,488H and U-69,593, on the binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to rat spinal cord and amygdala membranes.
    Rahmani NH, Gulati A, Bhargava HN.
    Pharmacology; 1991 Aug; 43(3):156-62. PubMed ID: 1663623
    [Abstract] [Full Text] [Related]

  • 4. Selective inhibition of the binding of 3H-(3-MeHis2) thyrotropin releasing hormone to rat amygdala membranes by some naturally occurring cannabinoids.
    Bhargava HN, Gulati A.
    Peptides; 1988 Aug; 9(4):771-5. PubMed ID: 2852360
    [Abstract] [Full Text] [Related]

  • 5. The binding of 3H-(3-MeHis2) thyrotropin releasing hormone to brain and pituitary membranes of morphine tolerant-dependent and abstinent rats.
    Bhargava HN, Das S, Bansinath M, Prasad R.
    Pharmacol Biochem Behav; 1989 Sep; 34(1):7-12. PubMed ID: 2516632
    [Abstract] [Full Text] [Related]

  • 6. Evidence for opiate action at the brain receptors for thyrotropin-releasing hormone.
    Bhargava HN, Das S.
    Brain Res; 1986 Mar 19; 368(2):262-7. PubMed ID: 3008927
    [Abstract] [Full Text] [Related]

  • 7. Proliferation of thyrotropin releasing hormone receptors in specific brain regions during the development of hypertension in spontaneously hypertensive rats.
    Bhargava HN, Das S, Bansinath M.
    Peptides; 1987 Mar 19; 8(2):231-5. PubMed ID: 3035513
    [Abstract] [Full Text] [Related]

  • 8. Down-regulation of central receptors for thyrotropin-releasing hormone in kappa opiate agonist-induced abstinence in the rat.
    Bhargava HN, Gulati A, Rahmani NH.
    Neuropharmacology; 1992 Feb 19; 31(2):137-41. PubMed ID: 1313157
    [Abstract] [Full Text] [Related]

  • 9. Binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to spinal cord membranes of spontaneously hypertensive and Wistar-Kyoto normotensive rats.
    Bhargava HN, Gulati A.
    Pharmacology; 1988 Feb 19; 37(6):349-55. PubMed ID: 2854272
    [Abstract] [Full Text] [Related]

  • 10. Benzodiazepine interactions with central thyroid-releasing hormone binding sites: characterization and physiological significance.
    Rinehart RK, Barbaz B, Iyengar S, Ambrose F, Steel DJ, Neale RF, Petrack B, Bittiger H, Wood PL, Williams M.
    J Pharmacol Exp Ther; 1986 Jul 19; 238(1):178-85. PubMed ID: 3014114
    [Abstract] [Full Text] [Related]

  • 11. Unidirectional interaction between thyrotropin releasing hormone and opiates at the level of their brain receptors.
    Das S, Bhargava HN.
    Gen Pharmacol; 1987 Jul 19; 18(1):99-102. PubMed ID: 3030873
    [Abstract] [Full Text] [Related]

  • 12. A novel substance P binding site in rat brain regions modulates TRH receptor binding.
    Sharif NA.
    Neurochem Res; 1990 Oct 19; 15(10):1045-9. PubMed ID: 1706485
    [Abstract] [Full Text] [Related]

  • 13. Affinities of opiate agonists and antagonists for the enkephalin receptors of rat brain.
    Wong DT, Horng JS.
    Res Commun Chem Pathol Pharmacol; 1977 Apr 19; 16(4):749-52. PubMed ID: 193169
    [Abstract] [Full Text] [Related]

  • 14. Stereoisomers of [3H]-N-allylnormetazocine bind to different sites in mouse brain.
    Martin BR, Katzen JS, Woods JA, Tripathi HL, Harris LS, May EL.
    J Pharmacol Exp Ther; 1984 Dec 19; 231(3):539-44. PubMed ID: 6094791
    [Abstract] [Full Text] [Related]

  • 15. Analogs of thyrotropin-releasing hormone (TRH): receptor affinities in brains, spinal cords, and pituitaries of different species.
    Sharif NA, To ZP, Whiting RL.
    Neurochem Res; 1991 Feb 19; 16(2):95-103. PubMed ID: 1652701
    [Abstract] [Full Text] [Related]

  • 16. Solubilization of receptors for thyrotropin-releasing hormone from GH4C1 rat pituitary cells: demonstration of guanyl nucleotide sensitivity.
    Sullivan NJ, Lautens LL, Tashjian AH.
    Mol Endocrinol; 1987 Dec 19; 1(12):889-98. PubMed ID: 2856405
    [Abstract] [Full Text] [Related]

  • 17. The stereoselective kappa-opioid receptor antagonist Mr 2266 does not exhibit stereoselectivity as an antagonist at the orphan opioid (ORL1) receptor.
    Bauer U, Nakazi M, Kathmann M, Göthert M, Schlicker E.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jan 19; 359(1):17-20. PubMed ID: 9933145
    [Abstract] [Full Text] [Related]

  • 18. The binding of 3H-(3-MeHis2) thyrotropin releasing hormone to brain membranes and temperature response to thyrotropin releasing hormone in different strains of mice.
    Bansinath M, Matwyshyn GA, Bhargava HN.
    Neuropharmacology; 1986 Aug 19; 25(8):923-6. PubMed ID: 3095676
    [Abstract] [Full Text] [Related]

  • 19. The binding of 3H-(3-MeHis2) thyrotropin releasing hormone to brain and pituitary membranes of hyperthyroid rats.
    Bhargava HN, Ramarao P, Gulati A, Matwyshyn GA, Prasad R.
    Arch Int Pharmacodyn Ther; 1989 Aug 19; 297():247-59. PubMed ID: 2499290
    [Abstract] [Full Text] [Related]

  • 20. Simultaneous modulation of TRH and opioid receptor binding in rat spinal cord after chronic naloxone administration.
    Krumins SA.
    Neuropeptides; 1988 Jan 19; 11(1):47-52. PubMed ID: 2835703
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.